Location of persisting mycobacteria in a Guinea pig model of tuberculosis revealed by r207910.
about
Multiple M. tuberculosis phenotypes in mouse and guinea pig lung tissue revealed by a dual-staining approachThe role of the novel exopolyphosphatase MT0516 in Mycobacterium tuberculosis drug tolerance and persistenceMathematical modeling of tuberculosis bacillary counts and cellular populations in the organs of infected mice.TMC207: the first compound of a new class of potent anti-tuberculosis drugsHeterogeneity in tuberculosis pathology, microenvironments and therapeutic responsesA medicinal chemists' guide to the unique difficulties of lead optimization for tuberculosisEvidence for oxidative stress and defective antioxidant response in guinea pigs with tuberculosisGlycolytic and Non-glycolytic Functions of Mycobacterium tuberculosis Fructose-1,6-bisphosphate Aldolase, an Essential Enzyme Produced by Replicating and Non-replicating BacilliIncreased expression of host iron-binding proteins precedes iron accumulation and calcification of primary lung lesions in experimental tuberculosis in the guinea pigLocation of intra- and extracellular M. tuberculosis populations in lungs of mice and guinea pigs during disease progression and after drug treatmentEfficacy of Mycobacterium indicus pranii immunotherapy as an adjunct to chemotherapy for tuberculosis and underlying immune responses in the lungThe Mycobacterium tuberculosis DosR regulon assists in metabolic homeostasis and enables rapid recovery from nonrespiring dormancyPentacyclic nitrofurans with in vivo efficacy and activity against nonreplicating Mycobacterium tuberculosisThree-dimensional in vitro models of granuloma to study bacteria-host interactions, drug-susceptibility, and resuscitation of dormant mycobacteriaGranuloma encapsulation is a key factor for containing tuberculosis infection in minipigsTuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primatesMycobacterial Cultures Contain Cell Size and Density Specific Sub-populations of Cells with Significant Differential Susceptibility to Antibiotics, Oxidative and Nitrite StressCytokine profiles in primary and secondary pulmonary granulomas of Guinea pigs with tuberculosis.Spectinamides are effective partner agents for the treatment of tuberculosis in multiple mouse infection modelsComparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig.Evaluation of standard chemotherapy in the guinea pig model of tuberculosisA Review of the Evidence for Using Bedaquiline (TMC207) to Treat Multi-Drug Resistant TuberculosisInterleukin-11 drives early lung inflammation during Mycobacterium tuberculosis infection in genetically susceptible mice.Low dose aerosol fitness at the innate phase of murine infection better predicts virulence amongst clinical strains of Mycobacterium tuberculosisThe stringent response is required for full virulence of Mycobacterium tuberculosis in guinea pigs.Uptake and accumulation of oxidized low-density lipoprotein during Mycobacterium tuberculosis infection in guinea pigs.Latent tuberculosis infection: myths, models, and molecular mechanismsActivities of TMC207, rifampin, and pyrazinamide against Mycobacterium tuberculosis infection in guinea pigs.Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes.A new recombinant BCG vaccine induces specific Th17 and Th1 effector cells with higher protective efficacy against tuberculosis.Dose-dependent activity of pyrazinamide in animal models of intracellular and extracellular tuberculosis infections.Contribution of the nitroimidazoles PA-824 and TBA-354 to the activity of novel regimens in murine models of tuberculosis.Impact of a low-oxygen environment on the efficacy of antimicrobials against intracellular Chlamydia trachomatis.bis-Molybdopterin guanine dinucleotide is required for persistence of Mycobacterium tuberculosis in guinea pigs.Effectiveness of tuberculosis chemotherapy correlates with resistance to Mycobacterium tuberculosis infection in animal modelsDevelopment of new vaccines and drugs for TB: limitations and potential strategic errorsNon-replicating Mycobacterium tuberculosis elicits a reduced infectivity profile with corresponding modifications to the cell wall and extracellular matrix.Post-exposure vaccination against Mycobacterium tuberculosis.The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells.Expression of antimicrobial drug tolerance by attached communities of Mycobacterium tuberculosis.
P2860
Q21090008-E8A79C96-0416-4439-8145-FB8F7E833EFDQ21134950-32789BA1-5AC6-458F-8029-FD31BB26CE3FQ21136107-4A573895-1C30-4981-8779-F353463B000CQ24632091-DE5F6D33-E25F-46D8-A701-18C1DB2DACC9Q26823503-C0651059-53EE-4170-93BC-DC465B7654F8Q27004482-E88B0D60-9CDC-48B6-B68A-3B2C4B528034Q27316510-277A7FD6-E8BF-4322-B502-60C532DB52DFQ27674487-0A291B82-3EEA-44F4-BD73-FC79217066D0Q28383746-5C52384D-7713-4041-A2E1-248647AF2EDDQ28477456-B309B120-28CB-4B3B-9B90-18984767665EQ28481571-F5DB3F18-6BDD-45DC-87C7-363B580CB7DDQ28487516-89000F38-F896-4D0F-B59F-2D6C09F3157AQ28539526-12E7D242-A801-4549-A4C2-EEE051746451Q28658279-2CB3CDD2-3B74-410A-BE08-F64707599B35Q28748169-0D02EF85-032C-494E-B63B-AFE73BC179BEQ29618010-C768240F-C663-4931-8E8C-05BFDCC6A831Q30842403-8C4BAB11-58DA-4390-A2D4-79CBDE7584B8Q33306790-8C412D83-82E7-4185-AFEF-CFB07E3E7D56Q33589762-4D880B58-C8F7-4580-A4D7-CAB64A855403Q33723589-29D70691-267F-4AE4-ABAE-7175F1569E95Q33826439-9809426E-06DD-42E7-B7E0-E4D1633F960BQ33939074-A2EC07BF-87BF-4A22-A376-8CA176AB4BEBQ33971136-75BFE9D4-E69E-4C75-995A-C9AFA5A772B2Q34123530-BFB23C40-943D-446C-899E-FD2099D66CF3Q34172559-A46375BF-0558-4C2A-8FB7-BCA7EFF7C655Q34228219-DC92E688-2166-4454-9915-E3A13EB0B6C5Q34297816-0D67143B-B7E5-40FE-B163-0973508E6C70Q34483596-A5DA7664-B113-44A4-B72B-73C6697D2161Q34512904-D2BF7EE0-5582-406D-BE43-04F5992B6C6CQ34513982-97A0831A-87C4-4FF5-8715-D80E61E7D176Q34737913-06C16F68-1D73-4E37-B5CF-9BCA599D6FEAQ34922056-6A31EFB8-0281-45B4-A188-69D76A716A00Q34932613-CDD3DE91-F60E-4A48-9697-967C410200EFQ34955543-645332A2-C7A6-4421-9854-13C810074030Q35037392-37B7D1F9-5642-4771-A31B-5B647BF26457Q35065531-B0E3FA34-4F24-44EB-BD09-D8E7C0F673E4Q35091433-86DF4DAA-2874-4D93-8841-F275ACF24E71Q35101154-ADC62DEA-9509-4F13-BDDB-A02FACE25189Q35125060-05C6F778-8648-4274-AC3C-BAFB20C60617Q35180731-EFFE4D97-95D7-4EC8-B7C8-A950B4587AB7
P2860
Location of persisting mycobacteria in a Guinea pig model of tuberculosis revealed by r207910.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Location of persisting mycobac ...... erculosis revealed by r207910.
@ast
Location of persisting mycobac ...... erculosis revealed by r207910.
@en
type
label
Location of persisting mycobac ...... erculosis revealed by r207910.
@ast
Location of persisting mycobac ...... erculosis revealed by r207910.
@en
prefLabel
Location of persisting mycobac ...... erculosis revealed by r207910.
@ast
Location of persisting mycobac ...... erculosis revealed by r207910.
@en
P2093
P2860
P356
P1476
Location of persisting mycobac ...... erculosis revealed by r207910.
@en
P2093
Anne J Lenaerts
Donald Hoff
Ian M Orme
Koen Andries
Luis Cantarero
Randall J Basaraba
Stefan Ehlers
P2860
P304
P356
10.1128/AAC.00276-07
P407
P577
2007-05-21T00:00:00Z